A Pilot Project to Evaluate the Benefit of Additional Support in Haematopoietic Cell Transplant (HCT) Research Data Management on Behalf of Anthony Nolan and BSBMTCT
Open Access
Abstract
Background: The participation of transplant centres in research studies that request detailed follow‐up data on included patients can be challenging due to the amount of time centre Data Managers have to complete additional requests. The Research Data Manager (RDM) Pilot Project was designed to support Anthony Nolan's longitudinal Patient/Donor project and provide real‐world evidence of the benefit of additional and dedicated data management resources in transplant centres. Objectives: For Anthony Nolan to continue advancing the field of donor selection, up‐to‐date and accurate follow‐up data is needed. This 12‐month pilot project aimed to demonstrate how on‐the‐ground support could improve access to outcome data. Study Design: Following RDM placements at two participating centres, we reviewed the data quality and quantity collected, thus ensuring the methods used remain effective and are likely to result in successful and continuous data improvement. The cohort covered a broad timespan and included historical patient records, posing challenges in availability of prior data and long‐term follow‐up of discharged patients. Results: Following the placements, over 400 patients now have the most up‐to‐date and complete patient clinical outcome data available within the EBMT/BSBMTCT registry database for any group to study, reducing the burden on these centres to complete research data requests for these individuals. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submissionKeywords
Funding Information
- Anthony Nolan
This publication has 15 references indexed in Scilit:
- Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 yearsBone Marrow Transplantation, 2021
- The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group Poster Session (P719-P721)Bone Marrow Transplantation, 2020
- Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 yearsBone Marrow Transplantation, 2020
- Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AMLBone Marrow Transplantation, 2020
- Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Bone Marrow Transplantation, 2019
- The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group – Poster SessionBone Marrow Transplantation, 2019
- Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective StudyTransplantation and Cellular Therapy, 2019
- Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplantsBone Marrow Transplantation, 2017
- Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donorsHaematologica, 2015
- Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantationBone Marrow Transplantation, 2014